About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Personalized Medicine
›
top-articles
Personalized Medicine
1.8
(top 50%)
impact factor
1.1K
(top 20%)
papers
10.3K
(top 20%)
citations
39
(top 20%)
h
-index
1.9
(top 50%)
impact factor
1.4K
all documents
11.3K
doc citations
66
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Personalized Medicine
2011
507
2
P4 medicine: how systems medicine will transform the healthcare sector and society
Personalized Medicine
2013
422
3
Wearables and the medical revolution
Personalized Medicine
2018
361
4
Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank
Personalized Medicine
2005
196
5
Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
Personalized Medicine
2010
155
6
The Googlization of health research: from disruptive innovation to disruptive ethics
Personalized Medicine
2016
105
7
Individual genomes and personalized medicine: life diversity and complexity
Personalized Medicine
2010
100
8
Biobanking in British Columbia: discussions of the future of personalized medicine through deliberative public engagement
Personalized Medicine
2008
96
9
Strategies for integrating personalized medicine into healthcare practice
Personalized Medicine
2017
93
10
Genotype–environment interactions and their translational implications
Personalized Medicine
2011
84
11
'Personalized medicine': what’s in a name?
Personalized Medicine
2014
82
12
Pharmacogenomics steps toward personalized medicine
Personalized Medicine
2005
72
13
A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy
Personalized Medicine
2012
71
14
Eyes wide open: the personal genome project, citizen science and veracity in informed consent
Personalized Medicine
2009
68
15
Clinician perspectives on using pharmacogenomics in clinical practice
Personalized Medicine
2015
67
16
Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing
Personalized Medicine
2012
66
17
Community pharmacists‘ attitudes towards clinical utility and ethical implications of pharmacogenetic testing
Personalized Medicine
2013
65
18
Translational systems biology of inflammation: potential applications to personalized medicine
Personalized Medicine
2010
61
19
Ethical, legal and social implications of incorporating personalized medicine into healthcare
Personalized Medicine
2015
60
20
Nutrigenomics and personalized nutrition: science and concept
Personalized Medicine
2008
57
21
Personalized medicine: challenges and opportunities for translational bioinformatics
Personalized Medicine
2013
57
22
Coriell Personalized Medicine Collaborative
®
: a prospective study of the utility of personalized medicine
Personalized Medicine
2010
55
23
Market access challenges in the EU for high medical value diagnostic tests
Personalized Medicine
2011
53
24
Influence ofCYP2C9genotype on warfarin dose among African–Americans and European–Americans
Personalized Medicine
2007
52
25
Individualizing warfarin therapy
Personalized Medicine
2007
51
26
Unraveling human complexity and disease with systems biology and personalized medicine
Personalized Medicine
2010
50
27
After the revolution? Ethical and social challenges in ‘personalized genomic medicine’
Personalized Medicine
2012
50
28
Primary care physician experiences with integrated pharmacogenomic testing in a community health system
Personalized Medicine
2017
49
29
Genomic information as a behavioral health intervention: can it work?
Personalized Medicine
2011
48
30
A critical view of the general public’s awareness and physicians’ opinion of the trends and potential pitfalls of genetic testing in Greece
Personalized Medicine
2011
47
31
Genetic susceptibility to bladder cancer risk and outcome
Personalized Medicine
2011
46
32
Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece
Personalized Medicine
2014
46
33
US FDA and personalized medicine:
in vitro
diagnostic regulatory perspective
Personalized Medicine
2010
45
34
Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare
Personalized Medicine
2012
45
35
HLA-Bgenotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine
Personalized Medicine
2005
44
36
National nursing workforce survey of nursing attitudes, knowledge and practice in genomics
Personalized Medicine
2013
44
37
Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers
Personalized Medicine
2013
44
38
Direct-to-consumer genetic testing: where and how does genetic counseling fit?
Personalized Medicine
2017
44
39
Personhood and solidarity: what kind of personalized medicine do we want?
Personalized Medicine
2014
43
40
Knowledge and attitudes concerning pharmacogenomics among healthcare professionals
Personalized Medicine
2011
40
41
The road from next-generation sequencing to personalized medicine
Personalized Medicine
2014
40
42
‘Someday it will be the norm’: physician perspectives on the utility of genome sequencing for patient care in the MedSeqProject
Personalized Medicine
2015
40
43
Machine learning for biomarker identification in cancer research – developments toward its clinical application
Personalized Medicine
2015
40
44
Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians
Personalized Medicine
2012
39
45
Enhancing diversity to reduce health information disparities and build an evidence base for genomic medicine
Personalized Medicine
2018
39
46
The unintended implications of blurring the line between research and clinical care in a genomic age
Personalized Medicine
2014
38
47
Quo vadis personalized medicine?
Personalized Medicine
2004
37
48
Genetics, genomics and society: the responsibilities of scientists for science communication and education
Personalized Medicine
2012
36
49
Genetics patients’ perspectives on clinical genomic testing
Personalized Medicine
2013
36
50
Medical student preparedness for an era of personalized medicine: findings from one US medical school
Personalized Medicine
2016
36
site/software ©
exaly
; All materials licenced under
CC by-SA
.